Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01086800 · ClinicalTrials.gov registry record · Phase 2
Heart Biomarker Evaluation in Apnea Treatment
A Phase 2 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 318
- Enrollment target
NCT01086800: Completed Phase 2 study, sponsored by Brigham and Women's Hospital.
NCT01086800 is a Phase 2 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 318 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (139% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01086800, a Phase 2 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 318 participants
- Enrollment target
Study Summary
This study examines the role of sleep apnea treatment in improving cardiovascular biomarkers.
Primary Outcome
* 24 hour blood pressure (BP) profile * Markers of systemic inflammation * Markers of oxidative stress * Prothrombotic markers * Sympathetic nervous system activity * Cardiac rhythm, impulse generation and ischemia * Dyslipidemia * Glucose regulation * Myocardial stress
Interventions
- OTHER Healthy Lifestyles and Sleep Education plus PAP
- OTHER Healthy Lifestyles and Sleep Education plus Supplemental Oxygen
- OTHER Healthy Lifestyles and Sleep Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
What the finished NCT01086800 record still lists
NCT01086800 is an interventional study that assigns participants to a tested intervention. The registered 318 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (139% higher).
The record links to 0 conditions, and to 3 interventions - of which Healthy Lifestyles and Sleep Education plus PAP is the first listed.
NCT01086800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01086800 about?
NCT01086800 is a clinical study titled "Heart Biomarker Evaluation in Apnea Treatment". This study examines the role of sleep apnea treatment in improving cardiovascular biomarkers.
What is the current status of trial NCT01086800?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 318 participants. The study started on 2010-02. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01086800?
The interventions under investigation include: Healthy Lifestyles and Sleep Education plus PAP (OTHER), Healthy Lifestyles and Sleep Education plus Supplemental Oxygen (OTHER), Healthy Lifestyles and Sleep Education (OTHER).
Who is sponsoring clinical trial NCT01086800?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01086800's enrollment target sits among peer trials
318 153rd of 2000 higher than 1,846 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05488340 · 318 participants · Phase 2
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
- NCT05675735 · 318 participants · NA
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder
- NCT05895786 · 318 participants · Phase 3
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- NCT06051617 · 318 participants · Phase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia